All posts by: Michael Zand

About Michael Zand

Researchers Publish Two New Methods for Analysis of CRISPR Off-Target Effects – GenomeWeb

Continue reading

2017-05-02 NEWS

Researchers Publish Two New Methods for Analysis of CRISPR Off-Target Effects
GenomeWeb
NEW YORK (GenomeWeb) – Two studies published simultaneously in Nature Methods yesterday describe new methods for analyzing the off-target effects of CRISPR/Cas-9 genome editing. One method identifies off-target mutations associated with …

Continue reading

2017-05-02 NEWS

Researchers Publish Two New Methods for Analysis of CRISPR Off-Target Effects
GenomeWeb
NEW YORK (GenomeWeb) – Two studies published simultaneously in Nature Methods yesterday describe new methods for analyzing the off-target effects of CRISPR/Cas-9 genome editing. One method identifies off-target mutations associated with …

Continue reading

2017-05-02 NEWS

California stem cell agency boss finds new job
San Francisco Business Times
Randy Mills, who came in to right California’s semi-public stem cell research funding agency, is leaving to head the National Marrow Donor Program. Mills three years ago came in as CEO of the California Institute for Regenerative Medicine with an eye

Continue reading

2017-05-02 NEWS

The Oracle Dispatch

Unproven stem cell therapies – promise versus evidence
BioNews
The ability of stem cells to divide into different mature cell types has ignited the field of regenerative medicine. Stem cells promise to repair and regenerate damaged or diseased tissues without the need for orthodox medical or surgical interventions
US Stem Cell Inc (OTCMKTS:USRM) Explodes Higher Ahead of RMAT DecisionThe Oracle Dispatch
US Stem Cell Inc (OTCMKTS:USRM) Extends Rise After Private Equity Firm Commits to Share PurchaseStreet Register
US Stem Cell Inc (OTCMKTS:USRM) Receives Institutional Fund InjectionStockNewsUnion
Lenox Ledger
all 5 news articles »
Continue reading

2017-05-02 NEWS

Daily Mail

CRISPR genetic tool will tackle cancer’s command centre
Daily Mail
The ‘cut and paste’ gene technique famous for transforming the way we can edit DNA has set its sights on cancer’s ‘command centre’. CRISPR-Cas9 is a modern ‘cut and paste’ tool for making precise edits in DNA. Researchers used the tool to target fusion …
CRISPR gene-editing tool targets cancer’s “command center”New Atlas
China Is Surging Ahead In The Race To Beat Cancer With CRISPRWall Street Pit
New CRISPR Technology May Be a Breakthrough for Low-Cost Disease DiagnosticsLexology (registration)
Lab News –University Herald –MIT News
all 12 news articles »